Echinocandin failure case due to a yet unreported FKS1 mutation in Candida krusei (original) (raw)

Antimicrobial Agents and Chemotherapy, 2011

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance

Hong Nguyen

Antimicrobial Agents and Chemotherapy, 2013

View PDFchevron_right

FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance

Naureen Iqbal

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Andrea Kwa

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment

Michaela Lackner

Antimicrobial agents and chemotherapy, 2014

View PDFchevron_right

FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance

Naureen Iqbal

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

David Perlin

Drug Resistance Updates, 2011

View PDFchevron_right

Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints

David Perlin

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

Naureen Iqbal

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations

David Perlin

View PDFchevron_right

Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin

M. Uzunov

Antimicrobial Agents and Chemotherapy, 2013

View PDFchevron_right

Novel FKS mutations associated with echinocandin resistance in Candida species

Joseph Chua

Antimicrobial agents …, 2010

View PDFchevron_right

FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia

abdullah abdullah

Clinical Infectious Diseases, 2014

View PDFchevron_right

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

mk vyas

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin

David Perlin

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Quick detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans

David Perlin

Journal of Clinical Microbiology, 2015

View PDFchevron_right

Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin

Donna Maccallum

Journal of Medical Microbiology, 2012

View PDFchevron_right

The Emergence of Echinocandin-Resistant Candida glabrata Exhibiting High MICs and Related FKS Mutations in Turkey

Dolunay Gülmez

2021

View PDFchevron_right

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

David Perlin

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr

David Perlin

Antimicrobial agents and chemotherapy, 2014

View PDFchevron_right

Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit

Micha Srour

Bone marrow transplantation, 2015

View PDFchevron_right

Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

Laura Judith Marcos Zambrano

Medical mycology, 2017

View PDFchevron_right

Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase

David Perlin

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin

Sara Gago

Antimicrobial agents and chemotherapy, 2012

View PDFchevron_right

Acquired resistance to echinocandins in Candida albicans: case report and review

Naji Aoun, Stephane Bretagne

Journal of Antimicrobial Chemotherapy, 2007

View PDFchevron_right

Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing

Stephane Bretagne

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Two echinocandin-resistant Candida glabrata FKS mutants from South Africa

Rindidzani Magobo

Medical Mycology Case Reports, 2016

View PDFchevron_right

Echinocandin failure case due to a yet unreported FKS1 mutation in Candida krusei (original) (raw)

Related papers